Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 4
1953 3
1954 3
1955 7
1956 4
1957 4
1958 5
1959 1
1961 7
1962 10
1963 14
1964 16
1965 14
1966 8
1967 16
1968 11
1969 24
1970 14
1971 26
1972 32
1973 14
1974 21
1975 44
1976 25
1977 33
1978 22
1979 16
1980 11
1981 29
1982 32
1983 51
1984 39
1985 38
1986 43
1987 45
1988 51
1989 45
1990 63
1991 67
1992 76
1993 73
1994 55
1995 70
1996 68
1997 65
1998 86
1999 85
2000 103
2001 108
2002 87
2003 94
2004 93
2005 75
2006 107
2007 98
2008 112
2009 129
2010 124
2011 158
2012 129
2013 136
2014 151
2015 131
2016 165
2017 125
2018 152
2019 179
2020 173
2021 89
Text availability
Article attribute
Article type
Publication date

Search Results

3,952 results
Results by year
Filters applied: . Clear all
Page 1
The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models.
Katayama R, Gong B, Togashi N, Miyamoto M, Kiga M, Iwasaki S, Kamai Y, Tominaga Y, Takeda Y, Kagoshima Y, Shimizu Y, Seto Y, Oh-Hara T, Koike S, Nakao N, Hanzawa H, Watanabe K, Yoda S, Yanagitani N, Hata AN, Shaw AT, Nishio M, Fujita N, Isoyama T. Katayama R, et al. Among authors: takeda y. Nat Commun. 2019 Aug 9;10(1):3604. doi: 10.1038/s41467-019-11496-z. Nat Commun. 2019. PMID: 31399568 Free PMC article.
Reply.
Takeda Y. Takeda Y. J Hypertens. 2019 Oct;37(10):2110-2111. doi: 10.1097/HJH.0000000000002196. J Hypertens. 2019. PMID: 31464864 No abstract available.
Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.
Osa A, Uenami T, Koyama S, Fujimoto K, Okuzaki D, Takimoto T, Hirata H, Yano Y, Yokota S, Kinehara Y, Naito Y, Otsuka T, Kanazu M, Kuroyama M, Hamaguchi M, Koba T, Futami Y, Ishijima M, Suga Y, Akazawa Y, Machiyama H, Iwahori K, Takamatsu H, Nagatomo I, Takeda Y, Kida H, Akbay EA, Hammerman PS, Wong KK, Dranoff G, Mori M, Kijima T, Kumanogoh A. Osa A, et al. Among authors: takeda y. JCI Insight. 2018 Oct 4;3(19):e59125. doi: 10.1172/jci.insight.59125. JCI Insight. 2018. PMID: 30282824 Free PMC article.
Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT).
Okada M, Kijima T, Aoe K, Kato T, Fujimoto N, Nakagawa K, Takeda Y, Hida T, Kanai K, Imamura F, Oizumi S, Takahashi T, Takenoyama M, Tanaka H, Hirano J, Namba Y, Ohe Y. Okada M, et al. Among authors: takeda y. Clin Cancer Res. 2019 Sep 15;25(18):5485-5492. doi: 10.1158/1078-0432.CCR-19-0103. Epub 2019 Jun 4. Clin Cancer Res. 2019. PMID: 31164373 Free article.
3,952 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page